CYP2D6 is one of the major enzymes in the cytochrome P450 monooxygenase system. It metabolizes ∼25% of prescribed drugs and hence, the genetic diversity of the CYP2D6 gene has continued to be of great interest to the medical and pharmaceutical industries. This study was designed to perform a systematic analysis of the CYP2D6 gene in six subtribes of the Malaysian Orang Asli.
Methods:
Genomic DNAs were extracted from the blood samples followed by whole-genome sequencing. The reads were aligned to the reference human genome hg19 and variants in the CYP2D6 gene were analyzed. CYP2D6*5 and duplication of CYP2D6 were analyzed using previously established methods.
Results:
A total of 72 single nucleotide polymorphisms were identified. CYP2D6*1, *2, *4, *5, *10,*41, and duplication of the gene were found in the Orang Asli, whereby CYP2D6*2 and *41 alleles are reported for the first time in the Malaysian population.
Conclusion:
The findings in this study provide insights into the genetic polymorphisms of CYP2D6 in the Orang Asli of Peninsular Malaysia.
Get full access to this article
View all access options for this article.
References
1.
AdithanC, GerardN, NaveenAT, et al. (2003) Genotype and allele frequency of CYP2D6 in Tamilian population. Eur J Clin Pharmacol, 59:517-520.
2.
AdzhubeiIA, SchmidtS, PeshkinL, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods, 7:248-249.
3.
AndrewsS (2010) FastQC: a quality control tool for high throughput sequence data.
4.
BarrettJC, FryB, MallerJ, et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21:263-265.
5.
BernardS, NevilleKA, NguyenAT, et al. (2006) Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist, 11:126-135.
6.
BertilssonL (1995) Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet, 29:192-209.
7.
BertilssonL, DahlML, DalenP, et al. (2002) Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol, 53:111-122.
FriedrichDC, GenroJP, SorticaVA, et al. (2014) Distribution of CYP2D6 alleles and phenotypes in the Brazilian population. PLoS One, 9:e110691.
10.
GaedigkA, CoetseeC (2008) The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements. Eur J Clin Pharmacol, 64:465-475.
11.
GaedigkA, SangkuhlK, Whirl-CarrilloM, et al. (2017) Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med, 19:69-76.
12.
GrieseEU, FauIK, KitteringhamNR, et al. (2001) Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia. Pharmacogenetics, 11:69-76.
13.
Ingelman-SundbergM (2004) Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol, 369:89-104.
14.
Ingelman-SundbergM (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J, 5:6-13.
15.
Ingelman-SundbergM, OscarsonM, McLellanRA (1999) Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol Sci, 20:342-349.
16.
IsmailR, TehLK (2001) Genetic polymorphism of CYP2D6: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia. Eur J Clin Pharmacol, 57:617-618.
17.
IsmailR, TehLK, AmirJ, et al. (2003) Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia. J Clin Pharm Ther, 28:279-284.
18.
JinTB, MaLF, ZhangJY, et al. (2013) Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population. Gene, 527:360-365.
19.
JohanssonI, Ingelman-SundbergM (2011) Genetic polymorphism and toxicology-with emphasis on cytochrome p450. Toxicol Sci, 120:1-13.
20.
LasimbangJ (2015) Malaysia. In: MikkelsenC (ed) The Indigenous World 2015. International Work Group for Indigenous Affairs (IWGIA), Copenhagen, pp 271-278.
21.
LeeSY, SohnKM, RyuJY, et al. (2006) Sequence-based CYP2D6 genotyping in the Korean population. Ther Drug Monit, 28:382-387.
22.
LiH, DurbinR (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25:1754-1760.
23.
LopezM, GuerreroJ, Jung-CookH, et al. (2005) CYP2D6 genotype and phenotype determination in a Mexican Mestizo population. Eur J Clin Pharmacol, 61: 749-754.
24.
LundqvistE, JohanssonI, Ingelman-SundbergM (1999) Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene, 226:327-338.
25.
MenoyoA, del RioE, BaigetM (2006) Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population. Cell Biochem Funct, 24:381-385.
26.
NgPC, HenikoffS (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res, 31:3812-3814.
27.
NiewinskiP, Orzechowska-JuzwenkoK, HurkaczM, et al. (2002) CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population. Eur J Clin Pharmacol, 58:533-535.
28.
NishidaY, FukudaT, YamamotoI, et al. (2000) CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10. Pharmacogenetics, 10:567-570.
29.
NurWaliyuddinHZ, NorazmiMN, EdinurHA, et al. (2015). Ancient genetic signatures of Orang Asli revealed by killer immunoglobulin-like receptor gene polymorphisms. PLoS One, 10:e0141536.
30.
QinS, ShenL, ZhangA, et al. (2008) Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China. Genomics, 92:152-158.
31.
RidegO, HaberA, BotzL, et al. (2011) Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population. Cell Biochem Funct, 29:562-568.
32.
SachseC, BrockmollerJ, Bauer, et al. (1997) Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet, 60:284-295.
33.
SamerCF, LorenziniKI, RollasonV, et al. (2013) Applications of CYP450 testing in the clinical setting. Mol Diagn Ther, 17:165-184.
34.
SherryST, WardMH, KholodovM, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res, 29:308-311.
35.
SteenVM, AndreassenOA, DalyAK, et al. (1995) Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics, 5:215-223.
36.
TehLK, BertilssonL (2012) Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance. Drug Metab Pharmacokinet, 27:55-67.
37.
TehLK, IsmailR, YusoffR, et al. (2001). Heterogeneity of the CYP2D6 gene among Malays in Malaysia. J Clin Pharm Ther, 26:205-211.
38.
Van der AuweraGA, CarneiroMO, HartlC, et al. (2013) From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics, 11:485.
39.
WanYJ, PolandRE, HanG, et al. (2001) Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern California. Pharmacogenetics, 11:489-499.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
